S6 kinase inhibitor
Cell permeable, ATP-competitive inhibitor of the four isoforms of ribosomal S6 kinase (p90 RSK) (IC50‘s at 100µM ATP: RSK1 = 31nM, RSK2 = 24nM, RSK3 = 18nM, RSK4 = 15nM). Does not significantly inhibit 10 other AGC kinases, and over 40 other protein kinases at 100X concentrations. Acts on the N-terminal AGC kinase domain. Completely prevents PMA-induced TSC2 phosphorylation.
Shipping: Available products typically ship within 24/48h, via priority shipping.
Do you need support? Contact Customer Service or Technical Support.
Online Account
Access or Create Your Account
Product Details
Alternative Name |
2-[(3,5-Difluoro-4-hydroxyphenyl)amino]-7,8-dihydro-5,7-dimethyl-8-(3-methylbutyl)-6(5H)-pteridone |
---|---|
Appearance |
Off-white solid. |
CAS |
501437-28-1 |
Couple Target |
S6 kinase |
Couple Type |
Inhibitor |
Formula |
C19H23F2N5O2 |
MW |
391.4 |
Purity |
≥98% (HPLC) |
Solubility |
Soluble in DMSO (>25mg/ml). |
Handling & Storage
Use/Stability |
As indicated on product label or CoA when stored as recommended. Stable for at least one year from the date of receipt when stored as supplied at -20°C |
---|---|
Handling |
Solutions can be stored at -20°C for up to 3 months. Protect from moisture and light. |
Long Term Storage |
-20°C |
Shipping |
Blue Ice |
Regulatory Status |
RUO – Research Use Only |
---|
- Ribosomal S6 kinase signaling regulates neuronal viability during development and confers resistance to excitotoxic cell death in mature neurons: K.R. Hoyt, et al.; Neuroscience 558, 1 (2024), Application(s): Treatment of neuronal cell cultures and stereotactic infusion of mouse brains, Abstract
- Receptor-independent modulation of cAMP-dependent protein kinase and protein phosphatase signaling in cardiac myocytes by oxidizing agents: S. Diering, et al.; J. Biol. Chem. 295, 15342 (2020), Abstract — Full Text
- Low concentrations of cadmium chloride promotes protein translation and improve cell line productivity: Mahameed, M., Obiedat, A., et al.; Biotechnol. Bioeng. 116, 569 (2019), Abstract
- Active Tonic mTORC1 Signals Shape Baseline Translation in Naive T Cells: Myers, D. R., Norlin, E., et al.; Cell Rep. 27, 1858 (2019), Abstract
- EphA2 phosphorylation at Ser897 by the Cdk1/MEK/ERK/RSK pathway regulates M-phase progression via maintenance of cortical rigidity: Y. Kaibori, et al.; FASEB J. 33, 5334 (2019), Abstract
- Human melanoma cells resistant to MAPK inhibitors can be effectively targeted by inhibition of the p90 ribosomal S6 kinase: C. Kosnopfel, et al.; Oncotarget 8, 35761 (2017), Application(s): Treatment of patient-derived melanoma cell and other primary cell cultures, Abstract — Full Text
- The Vascular Endothelial Growth Factor-A phosphorylates Murine Double Minute-2 on its Serine 166 via the Extracellular Signal-Regulated Kinase 1/2 and p90 Ribosomal S6 Kinase in primary human endothelial cells: J. Aiken & O. Birot; Biochem. Biophys. Res. Commun. 487, 1548 (2016), Abstract
- Feedback activation of neurofibromin terminates growth factor-induced Ras activation: Hennig, A., Markwart, R., et al.; Cell Commun. Signal. 14, 5 (2016), Abstract
- Phospholipase C∈ Activates Nuclear Factor-κB Signaling by Causing Cytoplasmic Localization of Ribosomal S6 Kinase and Facilitating Its Phosphorylation of Inhibitor κB in Colon Epithelial Cells: M. Wakita, et al.; J. Biol. Chem. 291, 12586 (2016), Application(s): Cell culture treatment, Abstract — Full Text
- ERK and RSK are necessary for TRH-induced inhibition of r-ERG potassium currents in rat pituitary GH3 cells: L. Carretero, et al.; Cell. Signal. 27, 1720 (2015), Application(s): Cell Culture, Abstract
- Simultaneous targeting of PI3Kδ and a PI3Kδ-dependent MEK1/2-Erk1/2 pathway for therapy in pediatric B-cell acute lymphoblastic leukemia: Wang, X., Zhang, X., et al.; Oncotarget 5, 10732 (2014), Abstract
- Modelling negative feedback networks for activating transcription factor 3 predicts a dominant role for miRNAs in immediate early gene regulation: Tindall, M. J., Clerk, A., et al.; PLoS Comput. Biol. 10, e1003597 (2014), Abstract
- Ribosomal S6 kinase regulates ischemia-induced progenitor cell proliferation in the adult mouse hippocampus: K. Karelina, et al.; Exp. Neurol. 253, 72 (2014), Application(s): Stereotactic injection in mice and treatment of primary mouse neurosphere cultures , Abstract — Full Text
- Phosphorylation of KIBRA by the extracellular signal-regulated kinase (ERK)–ribosomal S6 kinase (RSK) cascade modulates cell proliferation and migration: S. Yang, et al.; Cell. Signal. 26, 343 (2014), Application(s): Treatment of MCF-7 cell cultures, Abstract — Full Text
- p90 Ribosomal S6 kinases play a significant role in early gene regulation in the cardiomyocyte response to Gq-protein-coupled receptor stimuli, endothelin-1 and α1-adrenergic receptor agonists: E. Amirak, et al.; Biochem. J. 450, 351 (2013), Application(s): Rat cadiomyocyte treatment, Abstract — Full Text
- Synthetic Lethality Screen Identifies RPS6KA2 as Modifier of Epidermal Growth Factor Receptor Activity in Pancreatic Cancer: N. Milosevic, et al.; Neoplasia 15, 1354 (2013), Application(s): Cell culture treatment, Abstract — Full Text
- The p90 Ribosomal S6 Kinase (RSK) Is a Mediator of Smooth Muscle Contractility: M. Artamonov, et al.; PLoS One 8, e58703 (2013), Application(s): Treatment of rabbit pulmonary artery tissue, muscle tissue, and mouse ileum tissue cultures, Abstract — Full Text
- Phosphorylation of serine 4,642 in the C-terminus of plectin by MNK2 and PKA modulates its interaction with intermediate filaments: Bouameur, J. E., Schneider, Y., et al.; J. Cell Sci. 126, 4195 (2013), Abstract
- BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivo: G. Sapkota, et al.; Biochem. J. 401, 29 (2007), Abstract — Full Text
Datasheet, Manuals, SDS & CofA
Manuals And Inserts
Certificate of Analysis
Please enter the lot number as featured on the product label
SDS
Enzo Life Science provides GHS Compliant SDS
If your language is not available please fill out the SDS request form